Peter Gombrich is a serial entrepreneur having successfully founded three medical device companies. Under his leadership, he rose over $200 million and took several companies public. Peter founded CerMed in 2008, and has been working in the field of molecular diagnostics for women’s health for nearly 10 years. Prior to founding CerMed, he founded Diamics, a women’s healthcare company focused on cervical cancer screening. From 1992 to 2006, Peter

Irene Podolak has over 30 years of very broad experience in the health industry including positions in community based hospitals, large national healthcare consulting firms, an international information systems vendor, and a national health database corporation. She is a former Partner from the National Health Services Practice at Deloitte & Touche, where she was the founder and leader of the practice for over 10 years. Irene has had extensive co

Scott Christensen brings almost 35 years of medical device and early stage business development to CerMed. With a functional background in Marketing and Sales, he brings deep experience in developing and launching disruptive new technologies to the global marketplace. Most recently, Scott served as President and CEO of venture backed Dynatherm Medical, which was successfully acquired by a strategic partner in 2012. Prior to Dynatherm, Scott serv

Dr. Paul Vichi has over 15 years of research and development experience in oncology focused molecular biology and clinical microbiology, with previous faculty appointments in the departments of Biomedical Technology and Pathology at the University of Vermont, as well as senior positions for commercial R&D. Dr. Vichi joined CerMed in 2008, and is responsible for development of CerMed’s molecular Screening products. From 2005 – 2008, he was Senior

Linda Oleson has over 20 years of experience including execution and management of pre-clinical/clinical activities, product training for medical device startup companies and regulatory. She has provided consulting services through the full life cycle for numerous companies from inception through to acquisition and closure and has also lobbied successfully on legislation that supports entrepreneurs. In addition, Linda has worked with medical cons

20+ years of worldwide sales and marketing experience in the diagnostics, life sciences and biotech industry including specific experience in women’s health and infectious diseases. He has previous experience at Abbott Diagnostics, Igen (Roche) as well as a number of early stage companies. Alan holds an MBA from Oklahoma City University and a Bachelor of Science in Business Administration from Oklahoma State University.

Dr. Nam Kim is and experienced research and development scientist and manager with a track record of successfully implementing and executing development projects. He has over 20 years of experience in the pharma/biotech industry with expertise in the development of novel biomarkers and diagnostic tests. Dr. Kim holds a Ph.D. in Microbiology from the University of Toronto, Canada, an M.Sc. in Microbiology from the University of Toronto and a B.Sc.